HUP0000841A2 - Budesonidot tartalmazó, 0,28-0,38 g/ml szórósűrűségű, új inhalációs gyógyszerforma és eljárás előállítására - Google Patents

Budesonidot tartalmazó, 0,28-0,38 g/ml szórósűrűségű, új inhalációs gyógyszerforma és eljárás előállítására

Info

Publication number
HUP0000841A2
HUP0000841A2 HU0000841A HUP0000841A HUP0000841A2 HU P0000841 A2 HUP0000841 A2 HU P0000841A2 HU 0000841 A HU0000841 A HU 0000841A HU P0000841 A HUP0000841 A HU P0000841A HU P0000841 A2 HUP0000841 A2 HU P0000841A2
Authority
HU
Hungary
Prior art keywords
budesonide
bulk density
inhalation
preparation
new formulation
Prior art date
Application number
HU0000841A
Other languages
English (en)
Inventor
Jan Trofast
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20405452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0000841(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of HUP0000841A2 publication Critical patent/HUP0000841A2/hu
Publication of HUP0000841A3 publication Critical patent/HUP0000841A3/hu
Publication of HU228312B1 publication Critical patent/HU228312B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Abstract

A találmány tárgya új inhalációs gyógyszerforma, amely budesonid ésegy hordozó alapvetően egyenletes, finom eloszlású, mikronizáltrészecskéit tartalmazó, 0,28-0,38 g/ml szórósűrűségű porkészítmény, azelőállítására szolgáló eljárás - amely szerint a) a budesonidot és ahordozót mikronizálják; b) adott esetben a terméket kondicionálják; ésc) a porkeveréket szferonizálják, amíg a kívánt térfogatsűrűségetelérik. Ó
HU0000841A 1997-01-20 1998-01-13 New formulation for inhalation having a poured bulk density of from 0,28 to 0,38 g/ml, comprising budesonide HU228312B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700133A SE9700133D0 (sv) 1997-01-20 1997-01-20 New formulation
PCT/SE1998/000038 WO1998031350A1 (en) 1997-01-20 1998-01-13 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide

Publications (3)

Publication Number Publication Date
HUP0000841A2 true HUP0000841A2 (hu) 2000-10-28
HUP0000841A3 HUP0000841A3 (en) 2001-01-29
HU228312B1 HU228312B1 (en) 2013-03-28

Family

ID=20405452

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000841A HU228312B1 (en) 1997-01-20 1998-01-13 New formulation for inhalation having a poured bulk density of from 0,28 to 0,38 g/ml, comprising budesonide

Country Status (35)

Country Link
US (1) US6027714A (hu)
EP (1) EP1019033B1 (hu)
JP (1) JP2010059179A (hu)
KR (1) KR100528418B1 (hu)
CN (1) CN1222282C (hu)
AT (1) ATE389390T1 (hu)
AU (1) AU726916B2 (hu)
BE (1) BE1011400A5 (hu)
BR (1) BR9806892A (hu)
CA (1) CA2277914C (hu)
CZ (1) CZ295083B6 (hu)
DE (1) DE69839275T2 (hu)
DK (1) DK1019033T3 (hu)
EE (1) EE03998B1 (hu)
ES (2) ES2302348T3 (hu)
FR (1) FR2759908B1 (hu)
GR (1) GR1003290B (hu)
HK (1) HK1025516A1 (hu)
HU (1) HU228312B1 (hu)
ID (1) ID22883A (hu)
IE (1) IE980024A1 (hu)
IL (1) IL130840A (hu)
IS (1) IS2563B (hu)
NL (1) NL1008019C2 (hu)
NO (1) NO327451B1 (hu)
NZ (1) NZ336592A (hu)
PL (1) PL191569B1 (hu)
PT (1) PT1019033E (hu)
RU (1) RU2180563C2 (hu)
SE (1) SE9700133D0 (hu)
SI (1) SI1019033T1 (hu)
SK (1) SK283948B6 (hu)
TR (1) TR199901691T2 (hu)
UA (1) UA57762C2 (hu)
WO (1) WO1998031350A1 (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803770D0 (sv) * 1998-11-05 1998-11-05 Astra Ab Dry powder pharmaceutical formulation
EP1129705A1 (en) 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Powder formulation for inhalation
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
GB0012261D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
FR2809692A1 (fr) 2000-05-31 2001-12-07 Ecia Equip Composants Ind Auto Ensemble de masquage d'un coussin gonflable de securite pour vehicule automobile, procede de fabrication et planche de bord correspondante
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
US7931022B2 (en) * 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
SE0200657D0 (sv) * 2002-03-04 2002-03-04 Astrazeneca Ab Novel Formulation
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
CN100333727C (zh) * 2004-11-25 2007-08-29 天津药业研究院有限公司 布地奈德靶向微丸及其制备方法
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
DE102007049931A1 (de) 2007-10-18 2009-04-23 Pharmatech Gmbh Vorrichtung und Verfahren zur kontinuierlichen Herstellung von sphärischen Pulveragglomeraten
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
EP2821062A1 (en) 2013-07-01 2015-01-07 Arven Ilac Sanayi Ve Ticaret A.S. Novel dry powder inhaler formulations
AU2018318123A1 (en) 2017-08-15 2020-03-19 Nephron Pharmaceuticals Corporation Aqueous nebulization composition
JP2022549445A (ja) 2019-09-24 2022-11-25 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 吸入用乾燥粉末製剤のための新規担体粒子

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
SE438261B (sv) * 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
ATE23272T1 (de) * 1981-07-08 1986-11-15 Draco Ab Pulverinhalator.
DE3268533D1 (en) * 1981-07-24 1986-02-27 Fisons Plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
EP0705614B1 (en) * 1989-04-28 2002-09-25 Riker Laboratories, Inc. Dry powder inhalation device
US5176132A (en) * 1989-05-31 1993-01-05 Fisons Plc Medicament inhalation device and formulation
US5192548A (en) * 1990-04-30 1993-03-09 Riker Laboratoires, Inc. Device
SE9100342D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroid esters
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
DE69208660T2 (de) * 1991-06-10 1996-07-11 Schering Corp Fluorchlorkohlenwasserstoffreie aerosolformulierungen
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
PT613371E (pt) * 1991-12-18 2002-07-31 Astrazeneca Ab Nova combinacao de formoterol e budesonido
US5355872B1 (en) * 1992-03-04 1998-10-20 John H Riggs Low flow rate nebulizer apparatus and method of nebulization
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
EP0665010B1 (en) * 1992-10-16 2002-09-11 Nippon Shinyaku Company, Limited Method of manufacturing wax matrices
ATE209903T1 (de) * 1993-10-01 2001-12-15 Astrazeneca Ab Verfahren i
IS1736B (is) * 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
JPH10506406A (ja) * 1994-09-29 1998-06-23 アンダリス、リミテッド 治療用ビヒクルとしての噴霧乾燥させた微細粒子
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
US5647347A (en) * 1994-10-21 1997-07-15 Glaxo Wellcome Inc. Medicament carrier for dry powder inhalator
RU2071317C1 (ru) * 1994-12-21 1997-01-10 Александр Григорьевич Чучалин Лекарственный порошкообразный препарат для ингаляций
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
SE9603669D0 (sv) * 1996-10-08 1996-10-08 Astra Ab New combination

Also Published As

Publication number Publication date
JP2010059179A (ja) 2010-03-18
JP2001509811A (ja) 2001-07-24
NZ336592A (en) 2001-01-26
EP1019033B1 (en) 2008-03-19
EP1019033A1 (en) 2000-07-19
IL130840A0 (en) 2001-01-28
HU228312B1 (en) 2013-03-28
HUP0000841A3 (en) 2001-01-29
HK1025516A1 (en) 2000-11-17
SK283948B6 (sk) 2004-05-04
WO1998031350A1 (en) 1998-07-23
ES2302348T3 (es) 2008-07-01
SI1019033T1 (sl) 2008-08-31
ES2148059B1 (es) 2001-04-01
BR9806892A (pt) 2000-05-16
CN1243434A (zh) 2000-02-02
PL191569B1 (pl) 2006-06-30
RU2180563C2 (ru) 2002-03-20
EE03998B1 (et) 2003-04-15
NO993537L (no) 1999-09-17
SK95799A3 (en) 2000-01-18
GR980100021A (el) 1998-09-30
IL130840A (en) 2005-03-20
ES2148059A1 (es) 2000-10-01
GR1003290B (el) 2000-01-03
NO327451B1 (no) 2009-07-06
CA2277914A1 (en) 1998-07-23
TR199901691T2 (xx) 1999-09-21
CA2277914C (en) 2006-08-29
ATE389390T1 (de) 2008-04-15
FR2759908A1 (fr) 1998-08-28
EE9900320A (et) 2000-02-15
PT1019033E (pt) 2008-05-13
NL1008019A1 (nl) 1998-07-22
KR20000070186A (ko) 2000-11-25
CZ255599A3 (cs) 1999-10-13
FR2759908B1 (fr) 2000-04-21
PL334493A1 (en) 2000-02-28
ID22883A (id) 1999-12-16
SE9700133D0 (sv) 1997-01-20
UA57762C2 (uk) 2003-07-15
KR100528418B1 (ko) 2005-11-16
IE980024A1 (en) 1998-10-07
AU726916B2 (en) 2000-11-23
BE1011400A5 (fr) 1999-08-03
IS2563B (is) 2009-12-15
DE69839275T2 (de) 2009-04-02
CZ295083B6 (cs) 2005-05-18
JP4512202B2 (ja) 2010-07-28
CN1222282C (zh) 2005-10-12
NO993537D0 (no) 1999-07-19
NL1008019C2 (nl) 1998-12-16
DE69839275D1 (de) 2008-04-30
IS5110A (is) 1999-07-06
AU5785798A (en) 1998-08-07
DK1019033T3 (da) 2008-06-09
US6027714A (en) 2000-02-22

Similar Documents

Publication Publication Date Title
HUP0000841A2 (hu) Budesonidot tartalmazó, 0,28-0,38 g/ml szórósűrűségű, új inhalációs gyógyszerforma és eljárás előállítására
HUP0000714A2 (hu) 0,28-0,38 g/ml szórósűrűségű, új inhalációs gyógyszerforma, eljárás előállítására és alkalmazása
HUP0101608A2 (hu) Aeroszol formájú gyógyszerkészítmény és eljárás előállítására
HUP0104513A2 (hu) Javított minőségű porkészítmények
BR9909394A (pt) Composição de aerossol, composição farmacêutica, recipiente, dispositivo de inalação, processo para preparar uma composição de aerossol, mistura de um primeiro material particulado, e, processo para administrar um medicamento particulado
HUP0000843A2 (hu) Formoterolt tartalmazó, 028-0,38 g/ml szórósűrűségű, új inhalációs gyógyszerforma
HUP0004821A2 (hu) Lágy pellet alakjában lévő gyógyszerkészítmény és előállítása
HUP0000755A2 (hu) Terbutalin-szulfátot tartalmazó, 0,28-0,38 g/ml szórósűrűségű, új inhalációs gyógyszerforma, eljárás előállítására és alkalmazása
HUP0001780A2 (hu) Stabilizált tibolont tartalmazó készítmények és eljárás előállításukra
HUP0003207A2 (hu) Tokoferollal stabilizált proliposzóma porok inhalációs célra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HK1048064A1 (en) Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses
AP2000001837A0 (en) Pharmaceutical compositions containing micronized bicyclic drugs.
HUP0100398A2 (hu) Eljárás gyógyászati készítmény előállítására
JPS578280A (en) Aerosol suspension
TH53621B (th) สูตรผสมใหม่สำหรับการสูดลมหายใจเข้า

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: ASTRAZENECA AB,, SE

Free format text: FORMER OWNER(S): ASTRA AKTIEBOLAG, SE